 |
All specimens triaged by a pathologist to one of twenty different standard antibody panels |
 |
|
|
Custom designed panels dependent on suspected pathology or clinical circumstances |
|
|
|
Four-color (six parameter) data analyzed by hematopathologists using a powerful flexible approach known as “cluster analysis” |
|
|
|
Analysis strategy driven by characteristics of cell populations in the sample |
|
|
|
Final interpretations rendered by board-certified hematopathologists, and represent a synthesis of immunophenotypic, clinical and morphologic data |
|
Acute Leukemias |
|
|
|
Mature B & T Cell Neoplasms |
|
|
|
Multiple Myeloma and related disorders |
|
|
|
Myeloproliferative and Myelodysplastic disorders |
|
WBC & RBC surface antigens |
|
|
|
HIV monitoring |
|
|
|
Bronchial Alveolar Lavage (BAL) CD4/CD8 ratio for Sarcoidosis |
|
|
|
Rituximab monitoring (CD20 B Cells) |
|
|
|
CAMPATH monitoring (CD52) |
The Dynacare Flow Cytometry Laboratory is designed to provide rapid quantitative analysis of lymphocyte subsets and comprehensive qualitative analysis of a broad range of neoplastic disorders of the hematolymphoid system. Our Medical Director, Steven H. Kroft, MD, Hematopathologist is nationally recognized as an expert in the flow cytometric analysis of leukemia and lymphoma.
